Retour
Fourchette du Jour
180,33 €
184,84 €
Fourchette 52 Semaines
110,04 €
202,41 €
Volume
636 241
Moyenne 50J / 200J
184,31 €
/
156,87 €
Clôture Précédente
183,64 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 20,9 | 0,3 |
| P/B | 1,5 | 2,9 |
| ROE % | 7,4 | 3,7 |
| Net Margin % | 13,2 | 3,8 |
| Rev Growth 5Y % | -2,8 | 10,0 |
| D/E | 0,4 | 0,2 |
Objectif de Cours des Analystes
Hold
206,76 €
+12.4%
Low: 143,00 €
High: 250,00 €
P/E Prévisionnel
11,7
BPA Prévisionnel
15,76 €
Croissance BPA (est.)
+0,0%
CA Est.
9,4 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
18,14 €
17,06 € – 19,50 €
|
9,6 B | 3 |
| FY2029 |
17,96 €
16,89 € – 19,30 €
|
9,5 B | 3 |
| FY2028 |
17,34 €
15,65 € – 19,96 €
|
9,5 B | 9 |
Points Clés
Revenue declined -2,78% annually over 5 years
Earnings declined -20,76% over the past year
Debt/Equity of 0,38 — conservative balance sheet
Generating 2,05B in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 4,17%
Cash machine — converts 158,56% of earnings into free cash flow
Croissance
Revenue Growth (5Y)
-2,78%
Revenue (1Y)1,39%
Earnings (1Y)-20,76%
FCF Growth (3Y)28,82%
Qualité
Return on Equity
7,40%
ROIC5,59%
Net Margin13,18%
Op. Margin19,14%
Sécurité
Debt / Equity
0,38
Current Ratio2,68
Interest Coverage7,63
Valorisation
P/E Ratio
20,87
P/B Ratio1,48
EV/EBITDA16,48
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 1,39% | Revenue Growth (3Y) | -0,13% |
| Earnings Growth (1Y) | -20,76% | Earnings Growth (3Y) | 5,54% |
| Revenue Growth (5Y) | -2,78% | Earnings Growth (5Y) | -4,52% |
| Profitability | |||
| Revenue (TTM) | 9,81B | Net Income (TTM) | 1,29B |
| ROE | 7,40% | ROA | 4,39% |
| Gross Margin | 70,47% | Operating Margin | 19,14% |
| Net Margin | 13,18% | Free Cash Flow (TTM) | 2,05B |
| ROIC | 5,59% | FCF Growth (3Y) | 28,82% |
| Safety | |||
| Debt / Equity | 0,38 | Current Ratio | 2,68 |
| Interest Coverage | 7,63 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 20,87 | P/B Ratio | 1,48 |
| P/S Ratio | 2,75 | PEG Ratio | -0,95 |
| EV/EBITDA | 16,48 | Dividend Yield | 0,00% |
| Market Cap | 26,99B | Enterprise Value | 30,93B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 9,81B | 9,68B | 9,84B | 10,17B | 10,98B |
| Net Income | 1,29B | 1,63B | 1,16B | 3,05B | 1,56B |
| EPS (Diluted) | 8,83 | 11,19 | 7,97 | 20,87 | 10,40 |
| Gross Profit | 6,91B | 7,37B | 7,30B | 7,90B | 8,87B |
| Operating Income | 1,88B | 2,49B | 2,10B | 2,89B | 2,79B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 29,44B | 28,05B | 26,84B | 24,55B | 23,88B |
| Total Liabilities | 11,18B | 11,33B | 12,05B | 11,17B | 12,92B |
| Shareholders' Equity | 18,26B | 16,72B | 14,80B | 13,40B | 10,90B |
| Total Debt | 6,95B | 6,63B | 7,34B | 6,61B | 7,60B |
| Cash & Equivalents | 3,01B | 2,38B | 1,05B | 3,42B | 2,26B |
| Current Assets | 8,97B | 7,46B | 6,86B | 9,79B | 7,86B |
| Current Liabilities | 3,35B | 5,53B | 3,43B | 3,27B | 4,30B |